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The role of the social risk factors was diminished by low life conditions in 28(58%) patients. 
Active smoking was identified in 26 (54%), heavy alcohol consumption was established in 8 
(17%). The most of the patients 14 (29%) were detected by passive way, of which 12 (25%) 
cases were symptomatic. Screening of the high risk groups allowed the detection of 10 (21%) 
cases performed by the general practitioner and of 4 (8%) by the pulmonologist. All cases have 
never been treated for TB previously. Microbiological investigation revealed acid-fast-positive 
cases in 4 (8%) and GeneXpert in 5 (10%) cases. Epidemiological risk factors, such as TB 
contact and the membership of an infectious clusters were established in 8 (17%) and, 
accordingly, in 4 (8%) cases. The clinical-radiological diagnosis of pulmonary infiltrative was 
established in most cases 32(67%), with predominant localization in the upper segments S1 
and S2 in 27 (56%) cases. All patients were treated using the first anti-TB drugs. Successfully 
treated were 40 (92%) and 4 (8%) were lost to follow-up due to improvement of the general 
state and lack of desire to complete the treatment. 
Conclusions.  Most patients with pulmonary TB with limited forms encountered the social 
vulnerability. However, they timely contacted healthcare services, especially a general 
practitioner. Limited forms were localised predominantly in the upper segments, had a low 
indicator of microbiological positive results. Early detection of limited forms of TB has 
improved the outcome of the disease and can serve as a good example of an efficient case-
management. 
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Introduction. Sarcoidosis is a systemic granulomatous disorder of unknown cause that 
predominantly affects the lungs, more commonly seen in young adults. Considering the 
systemic character of the disease and that a great proportion of patients with sarcoidosis don’t 
present any symptoms, it is important to actively screen for other organ involvement  
Aim of the study. To identify the rate of extrapulmonary manifestations in patients with 
pulmonary sarcoidosis.  
Materials and methods. We have analyzed 41 consecutive sarcoidosis patients admitted to 
the Institute of Pthisiopneumology Hospital, Chisinau, Republic of Moldova within 2017-2019 
years.  
Results. In our study group the mean age was 54.5 ± 6.3 years, most of them were women (27 
(68.8%)), predominantly non-smokers (39 (78%)).  We found extrapulmonary manifestations 
in more than a half of patients (25 (60.9%)). 11 out of 25 (44%) had 2 extrapulmonary 
manifestations. The most frequent extrapulmonary manifestation was skin lesions, found in 13 
(31.7%) cases, joints involvement manifested by arthralgia and joint pain has been registered 
in 7 (17%) cases. Other manifestations were: eye lesions –found in 4 (9.7%) patients, peripheral 
lymph nodes – 4 (9.7%) individuals, liver involvement manifested as hepatomegaly – in 2 
(4.8%) cases, 3 (7.3%) patients had hypercalciuria, 3 (7.3%) patients had spleen enlargement 
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and heart involvement – 1 (2.4%) patient.  Although in our cohort all the patients had lung 
involvement, only 18 (41%) of them needed corticosteroid treatment for pulmonary lesions. 
Detecting other organs affected by sarcoidosis imposed corticosteroid treatment for other 11 
(26.8%) patients  
Conclusions. Extrapulmonary lesions in sarcoidosis in our study group was a common finding, 
seen in more than a half of patients with pulmonary sarcoidosis. The most frequent 
extrapulmonary manifestion was the skin lesions seen in about 1/3 of patients. Recognizing 
extrapulmonary organs affected by sarcoidosis, indicating signs of organ damage, changed the 
management plan in almost a quarter of patients.  
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Introduction. Obstructive sleep apnoea (OSA) is highly prevalent and there is considerable 
evidence supporting an independent association with a wide range of co-morbidities including 
cardiovascular, endocrine and metabolic, neuropsychiatric, pulmonary, and renal.  
Aim of the study. The objective of this study is to assess the prevalance of major comorbidities 
associated with obstructive sleep apnea (OSA) and to examine the predictive role of Charlson 
comorbidity index (CCI) on mortality of patients with OSA associated with comorbidities.  
Materials and methods. This is a cross-sectional study of 67 patients diagnosed with OSA 
based on antropometric dates,cardiorespiratory polygraphy and AHI.Inclusion criteria were 
patients with diagnosis of OSA, who were aged 18 and above and had comorbidities.  We 
assess patients with comorbodities through Charlson index adapted to International 
Classification of Disease (ICD-10) codes.  Charlson Comorbidity Index (CCI) (Charlson et al., 
1987) quantifies an individual’s burden of disease and corresponding 1-year mortality risk.  
Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk 
of mortality or resource use, and the sum of all the weights results in a single comorbidity score 
for a patient. A score of zero indicates that no comorbidities were found. The higher the score, 
the more likely the predicted outcome will result in mortality or higher resource use.  
Results. We evaluated 67 patients with OSA (51 men and 16 women) with a mean age of 53.9 
years (range 25–76 years). The prevalence of comorbidities were: hypertension (91%), obesity 
(85%), congestive heart failure (65%), pulmonary hypertension (26%), diabetes mellitus 
(25%), coronary heart disease (22%), etc. Based on the Charlson index of comorbidity the 
weighted index of comorbidity were: 0 for 6 patients, 1 for 17 patients,2 for 13 patients,3 for 
13 patients,4 for 11 patients, 5 for 5 patients and 6 for 2 patients. Combined condition and age-
related score were: 0 for 2 patients,1 for 8 patients,2 for 10 patients, 3 for 12 patients,4 for 9 
patients,5 for 8 patients,6 for 10 patients.7 for 1 patient and 8 for 1 patient.Patients with 
combined condition and age related score of 0 (2) estimated 10 year survival was 98 %, 1 (8) 
was 96%, 2 (10) was 90 %,3(12) was 77 %, 4 (9) was 53 %, 5 (9) was 21 %,6 was 2 %,7 was 
0 %,8 was 0 %.  
